Ticker Details
Neuronetics, Inc. Common Stock
IPO Date:	June 25, 2018
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$88.35M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.24 | 3.85%
Avg Daily Range (30 D):	$0.08 | 4.65%
Avg Daily Range (90 D):	$0.10 | 5.23%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	2.36M
Avg Daily Volume (90 D):	1.87M

Trade Size
Avg Trade Size (Sh.):	163
Avg Trade Size (Sh.) (30 D):	223
Avg Trade Size (Sh.) (90 D):	218

Institutional Trades
Total Institutional Trades:	155
Avg Institutional Trade:	$1.89M
Avg Institutional Trade (30 D):	$.58M
Avg Institutional Trade (90 D):	$.58M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.49M
Avg Closing Trade (30 D):	$.58M
Avg Closing Trade (90 D):	$.58M
Avg Closing Volume:	487.75K

News

Oct 31, 2025 @ 8:30 PM Neuronetics Reports Inducement Grant Under Nasdaq ... Source: Neuronetics, Inc.

Dec 10, 2024 @ 3:00 PM Neuronetics and Greenbrook TMS Announce Closing of... Source: N/A

Jul 2, 2024 @ 2:40 PM Neuronetics (STIM) Expands NeuroStar Portfolio Wit... Source: Zacks Equity Research

Jul 1, 2024 @ 12:02 PM NeuroStar® Launches Better Me Provider Program ... Source: Neuronetics

Jun 13, 2024 @ 12:31 PM NeuroStar Showcases Cutting-Edge Research at Clini... Source: Neuronetics

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.83	$-.13	$-.15
Diluted EPS	$-.83	$-.13	$-.15
Revenue	$129.87M	$37.3M	$38.11M
Gross Profit	$65.5M	$17.11M	$17.76M
Net Income / Loss	$-44.61M	$-9.4M	$-9.84M
Operating Income / Loss	$-37.87M	$-7.32M	$-8.06M
Cost of Revenue	$64.38M	$20.19M	$20.35M
Net Cash Flow	$22.82M	$17M	$-3.76M
PE Ratio